Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000111

Chief Medical Officer sold 3,705 shares at $43.85 ($162,464)

  • Chief Medical Officer acquired 8,375 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-01 Exercise or conversion : show line 1 in the form 10b5-1 +8,375 47,441 D
2024-07-01 Sale : show line 2 in the form 10b5-1 −3,705 $43.85 $162,464 43,736 D
Open-market sales · 3,705 sh · avg $43.85 · $162,464

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-07-01 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −8,375 16,749 D
Loading xslF345X05/wk-form4_1720038596.xml…